Fulltext

Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries

Fulcher GR 1 , Akhtar S 2 , Al-Jaser SJ 3 , Medina J 4 , Mohamed M 5 , Nicodemus NA 6 Show all authors , Olsen AH 4 , Singh KP 7 , Kok A 8

Affiliations 

  • 1 Department of Diabetes, Endocrinology and Metabolism, Royal North Shore Hospital, Sydney, NSW, 2065, Australia. greg.fulcher@sydney.edu.au
  • 2 Novo Nordisk Region Asia Pacific, Dubai, United Arab Emirates
  • 3 Department of Internal Medicine, Specialized Medical Center Hospital, Riyadh, Saudi Arabia
  • 4 Novo Nordisk A/S, Søborg, Denmark
  • 5 Department of Medicine, Hospital Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia
  • 6 Department of Biochemistry and Molecular Biology, University of the Philippines-College of Medicine, Manila, Philippines
  • 7 Department of Endocrinology, Fortis Hospital, Mohali, Punjab, India
  • 8 Netcare Union and Clinton Hospitals, Alberton, South Africa
Adv Ther, 2023 Jan;40(1):389-390.
PMID: 36315342 DOI: 10.1007/s12325-022-02349-1

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications